Does Wellcare Cover Contrave?
The verdict
Not Covered on most plans
Wellcare largely does not cover Contrave. As a Medicare/Medicaid-focused insurer (Centene), Wellcare's dominant readers are Part D and Medicaid members. Medicare Part D excludes Contrave by federal statute — this is not a plan choice. The 2026 GLP-1 Bridge does not cover oral AOMs. On Wellcare/Centene Medicaid, anti-obesity drug coverage is state-determined and often excluded. Commercial and ACA lines are not part of Wellcare's business. For most Wellcare members, CurAccess at approximately $99/month is the operative cost.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Wellcare using your member ID.
Key facts
Medicare Part D excludes weight-loss agents including Contrave by federal statute. This applies to all Medicare plans — Wellcare, Humana, and others — and is not a formulary decision.
CMS.gov, Medicare Part D statutory exclusions
The 2026 Medicare GLP-1 Bridge covers only Wegovy, Foundayo, and the Zepbound KwikPen — injectable weight-loss GLP-1s. Oral AOMs like Contrave are not in the Bridge.
CMS/Medicare.gov GLP-1 Bridge fact sheet
CurAccess (Currax) provides Contrave at approximately $99/month cash with free shipping — open to government-insured patients who do not bill their plan.
Currax Pharmaceuticals CurAccess program
Medicare vs. commercial coverage
Whether Wellcare covers Contrave depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D excludes weight-loss agents by statute (Medicare Modernization Act) — all Medicare plans, including Wellcare's, must follow this. The 2026 Medicare GLP-1 Bridge ($50/month, July 1 – Dec 31, 2027, processed by Humana) does NOT cover Contrave; the Bridge covers only Wegovy, Foundayo, and Zepbound KwikPen (specified injectable weight-loss GLP-1s). The manufacturer copay coupon explicitly excludes Medicare members. CurAccess (~$99/month cash) is open to government-insured patients who do not bill their plan.
Commercial / Employer
Group & marketplace plans
Wellcare (Centene) does not offer commercial/employer or ACA/individual insurance lines. Commercial and ACA coverage are n/a for Wellcare readers. On Wellcare/Centene Medicaid, anti-obesity drug coverage is state-determined: some Centene-administered state Medicaid plans exclude AOM entirely, others may cover less expensive oral agents (such as generic phentermine) but not Contrave. Coverage depends on the specific state preferred drug list — check your state's Medicaid PDL or contact Wellcare Medicaid directly.
Your cost, three ways
What Contrave actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Retail approximately $619 (Drugs.com) to $753 (SingleCare) per month.
List price with no coverage — before any manufacturer savings card.
With coverage
For the rare Centene Medicaid line that covers Contrave: cost depends on the state PDL tier. The manufacturer commercial copay coupon is irrelevant for Wellcare's government-insured readers.
Typical monthly copay once prior authorization is approved.
Bridge program
CurAccess (Currax): approximately $99/month with free shipping. The operative cash route for Wellcare's Medicare and Medicaid members, because manufacturer coupons explicitly exclude government insurance. Open to patients who do not bill their plan. No generic for Contrave.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Verify current pricing on your Wellcare/Centene plan's formulary.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Confirm coverage status on your Wellcare Medicare formulary
Search Wellcare's Medicare formulary for 'Contrave' or 'naltrexone/bupropion.' It will not appear as a covered drug under standard Medicare Part D — this is a statutory exclusion, not an oversight.
- 2
Check your state Medicaid PDL if you are on Wellcare Medicaid
Wellcare (Centene) administers Medicaid in multiple states. Anti-obesity drug coverage varies by state PDL. Look up your specific state Medicaid preferred drug list or call Wellcare's member services line for your state.
- 3
Consider the CurAccess cash program as your primary option
For Wellcare Medicare members especially, CurAccess at approximately $99/month with free shipping is the most direct path to Contrave. It is a cash program that does not require insurance coverage and is open to government-insured patients who choose not to bill their plan.
Options if Wellcare won't cover Contrave
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
CurAccess (Currax direct program)
Approximately $99/month cash with free shipping. The primary option for Wellcare Medicare and Medicaid members since coupons exclude government insurance.
Generic phentermine
Some Centene Medicaid state PDLs prefer generic phentermine as a low-cost non-incretin AOM (~$40 retail). Schedule IV controlled substance, FDA-approved for short-term weight management only.
Compounded semaglutide or tirzepatide (via Curex)
Injectable GLP-1-based weight-management option requiring no insurance or prior auth. Not the same medication as Contrave. From $49/month.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Federal law (the Medicare Modernization Act) prohibits Medicare Part D from covering drugs used primarily for weight loss. This is a statutory exclusion, not a plan-level decision — Wellcare cannot override it. The 2026 GLP-1 Bridge is a limited demonstration covering only specific injectable weight-loss GLP-1s and does not change the statutory exclusion for oral AOMs like Contrave.
No. The 2026 Medicare GLP-1 Bridge ($50/month fixed copay, July 1, 2026 – December 31, 2027) covers only Wegovy (all formulations), Foundayo, and the Zepbound KwikPen — all injectable weight-loss GLP-1s. Oral anti-obesity drugs like Contrave are not included. The Bridge does not change the statutory exclusion for Contrave on any Medicare plan, including Wellcare.
It depends on your state. Wellcare (Centene) administers Medicaid in multiple states, and each state's preferred drug list is different. Some Centene Medicaid plans exclude anti-obesity medications; others may cover inexpensive oral agents while excluding Contrave. Check your specific state Medicaid PDL or call Wellcare member services. Coverage is not guaranteed and varies widely.
No. The Contrave commercial copay coupon explicitly excludes Medicare, Medicaid, and TRICARE — all government-insured patients. The CurAccess program (approximately $99/month with free shipping) is a different program that operates as a cash price and is open to government-insured patients who choose not to bill their plan.
CurAccess is Currax Pharmaceuticals' direct cash program for Contrave at approximately $99/month with free shipping. Unlike the manufacturer coupon, CurAccess is open to cash-paying patients regardless of insurance type, including Medicare and Medicaid members. For Wellcare's predominantly government-insured population, where plan coverage of Contrave is either barred by law or state-restricted, CurAccess is the most accessible option.
Related Articles
Does Anthem Cover Contrave (Naltrexone/Bupropion)? 2026 | Curex
Anthem often excludes Contrave via AOM carve-outs; Medicare bars it by law. Where covered, BMI prior auth applies. CurAccess ~$99/mo is the cash route.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Kaiser Cover Contrave? 2026 HMO Formulary Guide | Curex
Kaiser often excludes Contrave — AOM carve-outs, Medicare statute, and Medi-Cal 2026 apply. Closed-network HMO limits access. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreDoes Oscar Health Cover Contrave? 2026 ACA Guide | Curex
Oscar marketplace plans frequently exclude Contrave. Where covered, BMI prior auth applies. CurAccess ~$99/mo beats the retail price for most members.
Read moreA weight-loss alternative that skips insurance and prior auth
Curex offers compounded semaglutide from $49/month and compounded tirzepatide from $149/month at getcurex.com/cl/glp — no insurance and no prior authorization required. This is compounded semaglutide/tirzepatide and is not the same medication as Contrave. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Contrave and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Wellcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Contrave and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.